Clinical Trial

Evaluating Health Outcomes of AI-Based Fitness Wearables and App Programs in Older Adults Living Alone With Cognitive Decline

Recruiting
View on ClinicalTrials.gov →
Summary
The overarching goal of our research is to develop personalized and accessible healthy aging lifestyle interventions aimed at promoting physical activity (PA) and improving health among community-dwelling older adults living alone with cognitive decline (LACD). To achieve this goal, the purpose of this project is to determine whether wearable and app-based mHealth intervention component(s) will contribute to increased PA and improved health outcomes in older adults LACD. Our specific aims are to: identify and evaluate mHealth intervention components that practically and significantly contribute to enhanced mechanistic outcomes (e.g., self-efficacy, outcome expectations) and increased PA (primary outcome) in older adults LACD over a 6-month period; determine the optimal combinations of intervention components for future efficacy testing; elucidate the mechanism of behavioral change (MoBC) and potential outcomes of these intervention components, namely, the mediating effects of MoBC variables (e.g., self-efficacy, outcome expectations) on the relationship between intervention components and change in PA. The first two aims are primary and fully-powered. The third aim is exploratory. The aims will support a refined, data-driven intervention design for a subsequent larger trial.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-06-16
notable Primary completion pushed: 2028-04-01 -> 2028-06-08 2026-06-16
minor Completion pushed: 2028-04-01 -> 2028-06-08 2026-06-16
Trial Details
NCT Number NCT07207993
Lead Sponsor The University of Tennessee, Knoxville
Collaborators: Arizona State University, Oregon Research Institute, National Institute on Aging (NIA)
Conditions Older Adults With Cognitive Decline, Older Adults, AI-Based Fitness, Wearables, Cognitive Decline, Physical Activity, Physical Inactivity
Enrollment 64 participants
Start Date 2026-06-08
Primary Completion 2028-06-08 (estimated)
Study Completion 2028-06-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-15